TB-500 acts systemically, mobilizing stem cells, suppressing inflammatory cytokines, and regulating actin for tissue remodeling
Two-year effects of semaglutide in adults with overweight or obesity (STEP 5)
Storage & Handling Upon receipt: Keep peptides cold and away from light
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
If any signs of injection site infection develop (increasing redness, warmth, swelling, or pain), discontinue use and consult a healthcare provider